Investors

 

UCB

UCB, Brussels, Belgium (www.ucb.com) is a biopharmaceutical company dedicated to the research, development and commercialization of innovative medicines with a focus on the fields of central nervous system and immunology disorders. Employing approximately 9 000 people in over 40 countries, UCB generated revenue of EUR 3.1 billion in 2009. UCB is listed on Euronext Brussels (symbol: UCB).

UCB NewMedicines is UCB’s discovery research through to clinical proof of concept organization established to secure the future pipeline of UCB. With strong technology platforms underpinning new products, UCB NewMedicines has an increased emphasis on external research and collaboration to sustain pipeline innovation. UCB NewMedicines was established in 2008 to focus on building the high-value and innovative early pipeline to kick-off the breakthrough phase of UCB’s roadmap.

Pfizer - Pfizer Inc: Working together for a healthier world™

Founded in 1849, Pfizer is the world's largest research-based pharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support. At Pfizer, more than 80,000 colleagues in more than 90 countries work every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide.

www.pfizer.com

TSB

Our vision is for the UK to be a global leader in innovation and a magnet for innovative businesses, where technology is applied rapidly, effectively and sustainably to create wealth and enhance quality of life.

www.innovateuk.org